351. The effects of sevoflurane anesthesia on insulin secretion and glucose metabolism in pigs.
- Author
-
Saho S, Kadota Y, Sameshima T, Miyao J, Tsurumaru T, and Yoshimura N
- Subjects
- Animals, Blood Glucose drug effects, Blood Glucose metabolism, Catecholamines metabolism, Dose-Response Relationship, Drug, Ethers blood, Glucose pharmacology, Glucose Tolerance Test, Insulin Secretion, Male, Pulmonary Alveoli metabolism, Sevoflurane, Swine, Anesthesia, General, Anesthetics, Inhalation, Ethers pharmacology, Glucose metabolism, Insulin metabolism, Methyl Ethers
- Abstract
We investigated the effects of two different concentrations of sevoflurane, 0.4 minimum alveolar anesthetic concentration (MAC) and 1.0 MAC, on insulin secretion before, during, and after sevoflurane anesthesia using three successive intravenous glucose tolerance tests (IVGTT) in pigs with indwelling catheters. We also investigated changes in the levels of plasma glucose, catecholamines (epinephrine [E], norepinephrine [NE]), and cortisol (Cor). The pigs were grouped as awake, 0.4 MAC, or 1.0 MAC. Sevoflurane decreased the ratio of insulin/glucose (INS/GLU) in the basal condition (P < 0.05 awake versus 1.0 MAC) and during IVGTT (P < 0.01 awake versus 1.0 MAC and 0.4 MAC). These decreases were quickly reversible (control levels were regained within 2 h of the end of anesthesia), were probably dose-related, appeared not to be mediated by E, NE, or Cor. In addition, the INS/GLU ratio 2.5-4 h after the end of anesthesia was significantly higher in the anesthetized groups than in the awake group. We conclude that sevoflurane anesthesia has a rapidly reversible inhibitory effect on basal and glucose-stimulated insulin secretion, as do other inhaled anesthetics, and might induce insulin resistance.
- Published
- 1997
- Full Text
- View/download PDF